| Health / Medical Topics |
Tivozanib
An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A benzodiazepine non-nucleoside reverse transcriptase inhibitor with activity against human immunodeficiency viruses 1 and 2 and simian immunodeficiency virus. Tivirapine inhibits replication…
A bicyclic heterocycle compound with activity against hepatitis B virus.
An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and…
A study in which the dosage of the intervention is increased by small increments until the desired physiological effect is seen. …
Adjust a condition by a dropwise addition of a solution.
An official descriptive name of a document, e.g. the long name of a study protocol provided by the study sponsor.
